Home Compliance Kaléo Agrees to $12.7 Million Settlement for Alleged Fraud and Kickbacks in... ComplianceNews Kaléo Agrees to $12.7 Million Settlement for Alleged Fraud and Kickbacks in Prescriptions for Anti-Overdose Drug November 15, 2021 9 Share FacebookLinkedinTwitter ShotPrime Studio | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Relator Alleged Violation of Statutes But Didn’t Adequately Plead False Certification Compliance Keeping the Lodestar Local — Mississippi Court Refuses to Apply D.C. Rates for FCA Fee Award Compliance Fraud-on-the-FDA is Not False for the FCA